A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer
Status:
Not yet recruiting
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
This trial is a single-arm, multicenter clinical study to evaluate the efficacy and safety of
Docetaxel for Injection (Albumin-bound) in patients with pancreatic cancer.